Literature DB >> 10463359

Apolipoprotein E and presenilin-1 genotypes in Huntington's disease.

M Panas1, D Avramopoulos, G Karadima, M B Petersen, D Vassilopoulos.   

Abstract

Huntington's disease (HD) is an autosomal dominant degenerative disease of the central nervous system manifested by involuntary movements (chorea), psychiatric manifestations, and cognitive impairment with a variable age at onset. This variability is mainly attributed to genetic factors. The so-called aging genes [e.g., those for apolipoprotein E (APOE) and presenilin-1 (PS-1) have been implicated in determining the age at onset of Alzheimer's disease, a disease sharing common clinical features with HD. In 60 unrelated patients suffering from HD (mean age at onset 40.1 years, range 20-65) we determined number of CAG repeats and the distribution of the APOE alleles (epsilon2, epsilon3, epsilon4) and PS-1 alleles. The results showed that: (a) The age at onset was higher in the group of patients with the epsilon4 allele (51.6 vs. 38.0 P<0.002), (b) The correlation between the age at onset and the number of CAG repeats was strong in patients with the epsilon3/epsilon3 genotype while it was not detected in patients with epsilon3/epsilon4 genotype. (c) No correlation was found between age at onset and PS-1 alleles. In conclusion, APOE seems to be a significant factor influencing the age at onset of Huntington's disease.

Entities:  

Mesh:

Substances:

Year:  1999        PMID: 10463359     DOI: 10.1007/s004150050406

Source DB:  PubMed          Journal:  J Neurol        ISSN: 0340-5354            Impact factor:   4.849


  10 in total

Review 1.  Huntington's disease: a decade beyond gene discovery.

Authors:  Penelope Hogarth
Journal:  Curr Neurol Neurosci Rep       Date:  2003-07       Impact factor: 5.081

2.  Replication of twelve association studies for Huntington's disease residual age of onset in large Venezuelan kindreds.

Authors:  J M Andresen; J Gayán; S S Cherny; D Brocklebank; G Alkorta-Aranburu; E A Addis; L R Cardon; D E Housman; N S Wexler
Journal:  J Med Genet       Date:  2006-10-03       Impact factor: 6.318

Review 3.  HDL and cognition in neurodegenerative disorders.

Authors:  David A Hottman; Dustin Chernick; Shaowu Cheng; Zhe Wang; Ling Li
Journal:  Neurobiol Dis       Date:  2014-08-13       Impact factor: 5.996

Review 4.  Huntington's Disease: Relationship Between Phenotype and Genotype.

Authors:  Yi-Min Sun; Yan-Bin Zhang; Zhi-Ying Wu
Journal:  Mol Neurobiol       Date:  2016-01-07       Impact factor: 5.590

5.  Apolipoprotein E genotypes do not influence the age of onset in Huntington's disease.

Authors:  C Saft; J E Andrich; N Brune; M Gencik; P H Kraus; H Przuntek; J T Epplen
Journal:  J Neurol Neurosurg Psychiatry       Date:  2004-12       Impact factor: 10.154

Review 6.  Statistical modeling of Huntington disease onset.

Authors:  Tanya P Garcia; Karen Marder; Yuanjia Wang
Journal:  Handb Clin Neurol       Date:  2017

7.  Population stratification may bias analysis of PGC-1α as a modifier of age at Huntington disease motor onset.

Authors:  Eliana Marisa Ramos; Jeanne C Latourelle; Ji-Hyun Lee; Tammy Gillis; Jayalakshmi S Mysore; Ferdinando Squitieri; Alba Di Pardo; Stefano Di Donato; Michael R Hayden; Patrick J Morrison; Martha Nance; Christopher A Ross; Russell L Margolis; Estrella Gomez-Tortosa; Carmen Ayuso; Oksana Suchowersky; Ronald J Trent; Elizabeth McCusker; Andrea Novelletto; Marina Frontali; Randi Jones; Tetsuo Ashizawa; Samuel Frank; Marie-Helene Saint-Hilaire; Steven M Hersch; Herminia D Rosas; Diane Lucente; Madaline B Harrison; Andrea Zanko; Karen Marder; James F Gusella; Jong-Min Lee; Isabel Alonso; Jorge Sequeiros; Richard H Myers; Marcy E Macdonald
Journal:  Hum Genet       Date:  2012-07-25       Impact factor: 4.132

8.  Function and comorbidities of apolipoprotein e in Alzheimer's disease.

Authors:  Valérie Leduc; Dorothée Domenger; Louis De Beaumont; Daphnée Lalonde; Stéphanie Bélanger-Jasmin; Judes Poirier
Journal:  Int J Alzheimers Dis       Date:  2011-04-05

9.  The role of apolipoprotein E as a risk factor for an earlier age at onset for Machado-Joseph disease is doubtful.

Authors:  Qi Zhou; Wang Ni; Yi Dong; Ning Wang; Shi-Rui Gan; Zhi-Ying Wu
Journal:  PLoS One       Date:  2014-11-04       Impact factor: 3.240

Review 10.  Huntington's disease.

Authors:  Marcy E MacDonald; Silvia Gines; James F Gusella; Vanessa C Wheeler
Journal:  Neuromolecular Med       Date:  2003       Impact factor: 4.103

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.